Mark Haas, MD, PhD

Professor of Pathology


Email: mark.haas@cshs.org
Phone: 310-423-6658


Specialties

  • Renal Pathology


Education and Training

  • Duke University, Durham, NC; MD
  • Duke University, Durham, NC; PhD
  • Residency in Anatomic Pathology, Yale - New Haven Medical Center, New Haven, CT
  • Fellowship in Renal Pathology, Yale - New Haven Medical Center, New Haven, CT


Medical Board Certification

  • Board Certified, Anatomic Pathology


Clinical and Research Interests

  • Renal Pathology, including glomerular diseases and transplantation pathology


Awards and Activities

  • Past-President, Renal Pathology Society
  • Recipient, Jacob Churg Award, Renal Pathology Society
  • Editorial Board Member, Kidney International
  • Section Editor (Glomerular Diseases), Clinical Nephrology


Selected Publications

  • Soloviova K., Puliaiev M, Haas M, Via CS.  In vivo maturation of allo-specific CD8 CTL and prevention of lupus-like graft-vs-host disease is critically dependent on T cell signaling through the TNF p75 receptor but not the TNF p55 receptor.  J. Immunol. 2013 (In press).
  • Haas M.  Pathology of C4d-negative antibody-mediated rejection in renal allografts.  Curr Opin Organ Transplant. 2013 (In press).
  • Haas M, Reich HN. Morphologic markers of progressive immunoglobulin A nephropathy. Adv Chronic Kidney Dis. 2012; 19:107-13.
  • Haas M. Pathologic features of antibody-mediated rejection in renal allografts: an expanding spectrum. Curr Opin Nephrol Hypertens. 2012; 21:264-71.
  • Mengel M, Sis B, Haas M, Colvin RB, et al. Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant. 2012;12:563-70.

Click here for a list of peer-reviewed publications by Mark Haas, MD, PhD.